Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SYVN1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | PPIC | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | IFI30 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | RABAC1 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | SH2B2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | SIPA1L3 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
mRNA | LRRK1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | TBC1D2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
mRNA | PAOX | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | WIPF1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |